Many cancer survivors face health-related quality of life issues

October 30, 2012 in Cancer

Oct. 30, 2012 – Beating cancer is just the first step.

More than one third of the 12.6 million in the United States have physical or mental problems that put their overall health in jeopardy, according to researchers at Wake Forest Baptist Medical Center.

Their study, published in the October issue of the journal Cancer Epidemiology, Biomarkers & Prevention, found that 25 percent of cancer survivors reported poor physical health and 10 percent reported poor mental health as compared to 10 percent and 6 percent, respectively, of adults without cancer.

The study was funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

"Until now, we didn't have clear data on quality-of-life issues for the population of U.S. cancer survivors," said the study's lead author, Kathryn Weaver, Ph.D., assistant professor of social sciences and health policy at Wake Forest Baptist. "This information should help doctors and researchers identify groups of survivors who may be at risk for long-term problems after cancer. In addition, it can help us know if some of the national efforts to improve life for cancer survivors are making a difference."

For the study, researchers analyzed data from a 2010 nationwide health survey conducted by the CDC that included data specific to cancer survivors collected by the CDC and the NCI. The scientists identified 1,822 cancer survivors and compared them with 24,804 adults with no history of cancer.

Survivors of breast cancer, prostate cancer and melanoma fared best, with health-related quality of life levels equivalent to or better than those of adults with no cancer history, according to the study.

In contrast, 40 percent of survivors of cervical, blood and colorectal cancers and survivors of cancers with a five-year survival rate of less than 25 percent (including cancers of the liver, lung and pancreas) were more likely to report physical problems that had a negative impact on their quality of life. In addition, survivors in the latter group were more likely to report mental health issues that affected their day-to-day lives.

The researchers estimated that about 3.3 million cancer survivors in the United States have poor physical health-related quality of life and almost 1.4 million have poor mental health-related quality of life.

"Recently, there has been a strong push for doctors to do a better job of communicating with cancer patients about what to expect as they finish treatment and transition to the survivor period," Weaver said. "Identifying what symptoms or problems cancer patients are facing after treatment – fatigue, pain, depression, sleep and cognition problems – and connecting them with the right resources or treatments is key to improving their long-term health."

Journal reference: Cancer Epidemiology, Biomarkers & Prevention search and more info website

Provided by Wake Forest University Baptist Medical Center search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Racial disparities in the surgical management of non-small cell lung cancer

The surgical management of non-small cell lung cancer (NSCLC) in U.S. hospitals varies widely depending on the race of the patient, according to a new study.

Cancer created 1 hour ago | popularity not rated yet | comments 0

Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency

Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progression of emphysema in patients ...

Cancer created 1 hour ago | popularity not rated yet | comments 0

New tumour-killer shows great promise in suppressing cancers

Scientists from Nanyang Technological University (NTU) and Lund University, Sweden, have bioengineered a novel molecule which has been proven to successfully kill tumour cells.

Cancer created 2 hours ago | popularity 5 / 5 (1) | comments 0

New factor to control oncogene-induced senescence

An article published on the journal Nature describes the major role that Pyruvate dehydrogenase (PDH) —an enzyme of cellular energy metabolism— plays in the regulation of the cellular senescence induce ...

Cancer created 2 hours ago | popularity not rated yet | comments 0

Anti-CD47 antibody may offer new route to successful cancer vaccination

(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...

Cancer created 4 hours ago | popularity not rated yet | comments 0 | with audio podcast


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Study shows where scene context happens in our brain

In a remote fishing community in Venezuela, a lone fisherman sits on a cliff overlooking the southern Caribbean Sea. This man –– the lookout –– is responsible for directing his comrades on the water, ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Genetic predictors of postpartum depression uncovered

Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.

Monoclonal antibody appears effective and safe in asthma Phase IIa trial

A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to U. S. researchers.